Conduit Pharmaceuticals Inc. (CDT)

Conduit Pharmaceuticals Inc. (CDT) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $209,159; returns 1 day -0.1%, 1 week -44.7%, 1 year -100.0%.

CDT Equity Inc. (formerly Conduit Pharmaceuticals Inc.) is a clinical-stage specialty biopharmaceutical company focused on developing and commercializing pharmaceutical products for unmet medical needs, particularly in the areas of autoimmune diseases and idiopathic male infertility.

Groups CDT belongs to

• Recent Reverse Splits
• Clinical Stage Biopharma
• Biotechnology
• Biopharmaceutical
• Pharmaceuticals
• Clinical Stage
• Autoimmune Diseases
• Unmet Medical Needs
• Healthcare

CDT financial model: income statement, cash flow and balance sheet